Price, G. W.; Burton, M. J.; Collin, L. J.; Duckworth, M.; Gaster, L.; Göthert, M.; Jones, B. J.; Roberts, C.; Watson, J. M.; Middlemiss, D. N. (1997). „SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 9303567 (3): 312—320. PMID9303567. S2CID26760453. doi:10.1007/pl00005056.
Schlicker, E.; Fink, K.; Molderings, G. J.; Price, G. W.; Duckworth, M.; Gaster, L.; Middlemiss, D. N.; Zentner, J.; Likungu, J.; Göthert, M. (1997). „Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 9303568 (3): 321—327. PMID9303568. S2CID12246022. doi:10.1007/pl00005057.
Goadsby, P. J.; Classey, J. D. (2003). „Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input”. Neuroscience. 14614913 (2): 491—498. PMID14614913. S2CID24825348. doi:10.1016/s0306-4522(03)00570-0.
nih.gov
ncbi.nlm.nih.gov
Price, G. W.; Burton, M. J.; Collin, L. J.; Duckworth, M.; Gaster, L.; Göthert, M.; Jones, B. J.; Roberts, C.; Watson, J. M.; Middlemiss, D. N. (1997). „SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 9303567 (3): 312—320. PMID9303567. S2CID26760453. doi:10.1007/pl00005056.
Schlicker, E.; Fink, K.; Molderings, G. J.; Price, G. W.; Duckworth, M.; Gaster, L.; Middlemiss, D. N.; Zentner, J.; Likungu, J.; Göthert, M. (1997). „Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 9303568 (3): 321—327. PMID9303568. S2CID12246022. doi:10.1007/pl00005057.
Goadsby, P. J.; Classey, J. D. (2003). „Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input”. Neuroscience. 14614913 (2): 491—498. PMID14614913. S2CID24825348. doi:10.1016/s0306-4522(03)00570-0.
semanticscholar.org
api.semanticscholar.org
Price, G. W.; Burton, M. J.; Collin, L. J.; Duckworth, M.; Gaster, L.; Göthert, M.; Jones, B. J.; Roberts, C.; Watson, J. M.; Middlemiss, D. N. (1997). „SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 9303567 (3): 312—320. PMID9303567. S2CID26760453. doi:10.1007/pl00005056.
Schlicker, E.; Fink, K.; Molderings, G. J.; Price, G. W.; Duckworth, M.; Gaster, L.; Middlemiss, D. N.; Zentner, J.; Likungu, J.; Göthert, M. (1997). „Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 9303568 (3): 321—327. PMID9303568. S2CID12246022. doi:10.1007/pl00005057.
Goadsby, P. J.; Classey, J. D. (2003). „Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input”. Neuroscience. 14614913 (2): 491—498. PMID14614913. S2CID24825348. doi:10.1016/s0306-4522(03)00570-0.